Currently FDA Authorized for use in Clinical Labs

Currently FDA Authorized for use outside Clinical Labs

University of California, Santa Cruz

Smith College

Currently Used Methods for Diagnosis

Cheng MP, Papenburg J, Desjardins M, et al. Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review. Ann Intern Med. 2020;172(11):726-734. doi:10.7326/M20-1301

https://pubmed.ncbi.nlm.nih.gov/32282894/

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2

Testing for COVID-19. (n.d.). Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Testing for COVID-19

Diagnostic Testing methods that amplify DNA using reverse transcriptase.
Nucleic Acid Amplification Tests include but are not limited to:

- RT-PCR
- RT-LAMP
- Next Generation Sequencing
- Isothermal Nucleic Acid Amplification
- RPA

NAAT

Detection Methods Used Currently by Manufacturers

(Please indicate "current" date if not stated elsewhere)

- CDC
- WHO

Detection Methods Used Currently by Organizations

Imaging tests cannot be used as the only reliable diagnostic tool to detect infection due to its lack of sensitivity. However, it can be useful in medical settings with limited resources where the virus is prevalent.

- Chest Radiograph
- Ultrasound
- Computed Tomography

Radiographics Test / CT Imaging for COVID-19

The use of antibody-testing with a similar sensitivity and specificity to RT-PCR. However, the virus is detected in a later state (10-20 days into the infection). 
- SVN
- ELISA
- LFIA


Learn Before

Related

Learn After